HomeCompareAVCNF vs JEPQ

AVCNF vs JEPQ: Dividend Comparison 2026

AVCNF yields 1666.67% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AVCNF wins by $1839785666.21M in total portfolio value
10 years
AVCNF
AVCNF
● Live price
1666.67%
Share price
$0.12
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1839785666.26M
Annual income
$1,645,561,548,268,653.00
Full AVCNF calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — AVCNF vs JEPQ

📍 AVCNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAVCNFJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AVCNF + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AVCNF pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVCNF
Annual income on $10K today (after 15% tax)
$141,666.67/yr
After 10yr DRIP, annual income (after tax)
$1,398,727,316,028,355.00/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, AVCNF beats the other by $1,398,727,316,026,525.20/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVCNF + JEPQ for your $10,000?

AVCNF: 50%JEPQ: 50%
100% JEPQ50/50100% AVCNF
Portfolio after 10yr
$919892833.15M
Annual income
$822,780,774,135,402.80/yr
Blended yield
89.44%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVCNF buys
0
JEPQ buys
0
No recent congressional trades found for AVCNF or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAVCNFJEPQ
Forward yield1666.67%11.10%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$1839785666.26M$44.8K
Annual income after 10y$1,645,561,548,268,653.00$2,152.59
Total dividends collected$1825787439.21M$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: AVCNF vs JEPQ ($10,000, DRIP)

YearAVCNF PortfolioAVCNF Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$177,367$166,666.67$11,930$1,110.39+$165.4KAVCNF
2$2,952,503$2,762,720.66$14,133$1,224.34+$2.94MAVCNF
3$46,139,686$42,980,507.73$16,632$1,340.46+$46.12MAVCNF
4$677,098,258$627,728,794.51$19,454$1,457.97+$677.08MAVCNF
5$9,333,745,461$8,609,250,324.41$22,626$1,576.08+$9333.72MAVCNF
6$120,900,966,251$110,913,858,608.07$26,175$1,694.09+$120900.94MAVCNF
7$1,472,054,345,780$1,342,690,311,890.92$30,133$1,811.32+$1472054.32MAVCNF
8$16,853,789,214,559$15,278,691,064,574.45$34,531$1,927.17+$16853789.18MAVCNF
9$181,517,867,281,133$163,484,312,821,554.84$39,403$2,041.08+$181517867.24MAVCNF
10$1,839,785,666,259,465$1,645,561,548,268,653.00$44,787$2,152.59+$1839785666.21MAVCNF

AVCNF vs JEPQ: Complete Analysis 2026

AVCNFStock

Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research and development of evidence-based products for consumer medical and pharmaceutical segments worldwide. The company collaborates with Canadian academic and medical institutions. Its scientific platform includes research and development, and clinical development that leads to the commercialization of approximately twenty products across four main market segments. The company provides medical and wellness products containing cannabidiol, cannabigerol, and tetrahydrocannabinol under the RHO Phyto brand; functional CBD consumer derma-cosmetic and topical products under the Pura H&W and Pura Earth brand names; and cannabis dried flowers, standardized seeds, full spectrum extracts, cannabinoid distillates, isolated cannabinoids, and bulk formulations derived from hemp and cannabis cultivars under the Aureus brand. It also develops pharmaceutical products for epidermolysis bullosa, dermatology, chronic pain, and various neurological disorders. The company has research collaboration with Dr. Christine Allen'sResearch Group for the development of a cannabinoid-based treatment for lung inflammation associated with COVID19. Avicanna Inc. was incorporated in 2016 and is headquartered in Toronto, Canada.

Full AVCNF Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this AVCNF vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVCNF vs SCHDAVCNF vs JEPIAVCNF vs OAVCNF vs KOAVCNF vs MAINAVCNF vs XYLDAVCNF vs QYLDAVCNF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.